000			03663nam a22004095i 4500
001			978-3-7091-0442-2
003			DE-He213
005			20140220082925.0
007			cr nn 008mamaa
008			130216s2013 au | s |||| 0|eng d
020			_a9783709104422 _9978-3-7091-0442-2
024	7		_a10.1007/978-3-7091-0442-2 _2doi
050		4	_aRS1-441
072		7	_aMQP _2bicssc
072		7	_aMED072000 _2bisacsh
082	0	4	_a615.1 _223
100	1		_aWagner, Hildebert. _eeditor.
245	1	0	_aEvidence and Rational Based Research on Chinese Drugs _h[electronic resource] / _cedited by Hildebert Wagner, Gudrun Ulrich-Merzenich.
264		1	_aVienna : _bSpringer Vienna : _bImprint: Springer, _c2013.
300			_aXII, 525 p. 125 illus., 75 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aDevelopment of New Analytical Monographs of TCM-drugs for Quality Proof and Development of new Phytopharmaceuticals -- DNA-based authentication of TCM-plants: Current Progress and Future Perspectives -- Newest Results of the Chemistry and Pharmacology of Triterpen- and Steroid-Saponins containing TCM-drugs -- Efficacy of Andrographis paniculata in upper respiratory tract (URT) infectious diseases and the mechanisms of action -- Chemical Composition, experimental and Clinical Pharmacology of Hippohae rhamnoides (buckthorn berries and leaves) -- New results of the Pharmacology and Clinic of the TCM-drugs Salvia miltiorhiza -- Phytochemicals from Traditional Chinese Medicine (TCM) as novel adjuncts for Cancer Therapy I -- New results of Artesunate for cancer therapy -- Chinese herbal medicine for the treatment of ischemic stroke: promise and reality -- Complementary and Traditional Chinese Medicine (TCM) in the treatment of gynaecological diseases -- Ginkgo biloba extract EGb761 : From an ancient Asian plant to a modern European herbal medicinal product -- Gingkolides and Their Derivatives: Synthetic and Biorganic Studies -- Evidence based modernisation of TCM.
520			_aAfter the successful introduction of acupuncture to the West, recent advances in analytical methods in chemistry, molecular biology and system biology – especially the development of the “omic” technologies – have again brought Chinese drugs into the focus of research on Traditional Chinese Medicine (TCM). With more than 1000 publications on the chemistry, molecular biology and pharmacology of TCM drugs in international journals over the last 10 years, Chinese drugs are gaining increasingly reputation and impact. These data offer great opportunities for the development of new pharmaceuticals for various clinical applications. International Scientists have compiled relevant and trend setting research results in this book. Topics range from the latest methods of quality and safety assurance by chemical and genetic fingerprints to the development of new pharmaceuticals for a future evidence-based therapy e.g. for cancer, cardiovascular, inflammatory or infectious diseases as well as to recent experimental results on multitarget and synergy research for the preparation of multi-extract-pharmaceuticals from TCM.
650		0	_aPharmacy.
650	1	4	_aPharmacy.
650	2	4	_aPharmacy.
700	1		_aUlrich-Merzenich, Gudrun. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783709104415
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-7091-0442-2
912			_aZDB-2-SME
999			_c98951 _d98951